Compare Stocks: TVTX vs. ERAS vs. CRSP vs. CGON
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
TVTXERASCRSPCGON
Market Snapshot
Current market context for the selected companies.
TVTX
$65.10
Market Cap
$6.19B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
ERAS
$17.44
Market Cap
$6.17B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
CRSP
$57.31
Market Cap
$5.75B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
CGON
$78.67
Market Cap
$7.07B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-24
Performance
Absolute returns and relative performance versus SPY.
| Metric | TVTX | ERAS | CRSP | CGON |
|---|---|---|---|---|
| 1 Month | +13.5% | -8.7% | +23.2% | +13.5% |
| 1 Month vs SPY | +10.1% | -12.1% | +19.8% | +10.1% |
| 3 Months | +46.5% | +55.2% | +13.8% | +22.4% |
| 3 Months vs SPY | +44.1% | +52.7% | +11.4% | +20.0% |
| 6 Months | +111.8% | +33.9% | +6.2% | +34.9% |
| 6 Months vs SPY | +99.9% | +22.0% | -5.8% | +23.0% |
| 1 Year | +265.9% | +1062.7% | +8.5% | +202.8% |
| 1 Year vs SPY | +245.7% | +1042.5% | -11.7% | +182.6% |
| 2 Years | +623.3% | +534.2% | +15.0% | +118.0% |
| 2 Years vs SPY | +586.8% | +497.7% | -21.5% | +81.5% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.